[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.82.105. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Medical News & Perspectives
March 17, 1999

Ovarian Cancer Investigators Aim at Cell Signaling Pathways

Author Affiliations
 

Not Available

Not Available

JAMA. 1999;281(11):973-975. doi:10.1001/jama.281.11.973

Houston—Identification of the cellular and genetic abnormalities involved in all types of cancer is providing new therapeutic avenues for researchers to pursue. Efforts to translate this knowledge into innovative therapies for ovarian cancer took the spotlight at the first International Conference on Ovarian Cancer, held at the University of Texas last month.

Ovarian cancer, which has the highest mortality rate of all gynecologic cancers and is the fourth leading cause of cancer deaths among women in the United States, can usually be treated and cured if caught early. But all too often, it causes only vague symptoms that go unnoticed until the tumor is advanced and the prognosis is poor.

First Page Preview View Large
First page PDF preview
First page PDF preview
×